CN111479577A - 用于增强癌症放疗的组合物和方法 - Google Patents

用于增强癌症放疗的组合物和方法 Download PDF

Info

Publication number
CN111479577A
CN111479577A CN201880047692.1A CN201880047692A CN111479577A CN 111479577 A CN111479577 A CN 111479577A CN 201880047692 A CN201880047692 A CN 201880047692A CN 111479577 A CN111479577 A CN 111479577A
Authority
CN
China
Prior art keywords
nutritional supplement
supplement
radiotherapy
selenium
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880047692.1A
Other languages
English (en)
Chinese (zh)
Inventor
夏滉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202510209330.XA priority Critical patent/CN120695036A/zh
Publication of CN111479577A publication Critical patent/CN111479577A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1626—Selenium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/204—Animal extracts
    • A23V2250/2042—Marine animal, fish extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
CN201880047692.1A 2017-06-13 2018-06-13 用于增强癌症放疗的组合物和方法 Pending CN111479577A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202510209330.XA CN120695036A (zh) 2017-06-13 2018-06-13 用于增强癌症放疗的组合物和方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762519087P 2017-06-13 2017-06-13
US62/519,087 2017-06-13
PCT/US2018/037263 WO2018231937A2 (en) 2017-06-13 2018-06-13 Compositions and methods for enhancing cancer radiotherapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202510209330.XA Division CN120695036A (zh) 2017-06-13 2018-06-13 用于增强癌症放疗的组合物和方法

Publications (1)

Publication Number Publication Date
CN111479577A true CN111479577A (zh) 2020-07-31

Family

ID=64658660

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201880047692.1A Pending CN111479577A (zh) 2017-06-13 2018-06-13 用于增强癌症放疗的组合物和方法
CN202510209330.XA Pending CN120695036A (zh) 2017-06-13 2018-06-13 用于增强癌症放疗的组合物和方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202510209330.XA Pending CN120695036A (zh) 2017-06-13 2018-06-13 用于增强癌症放疗的组合物和方法

Country Status (9)

Country Link
US (2) US10905723B2 (enExample)
EP (1) EP3638269B1 (enExample)
JP (3) JP7336993B2 (enExample)
KR (2) KR102775757B1 (enExample)
CN (2) CN111479577A (enExample)
CA (1) CA3066749A1 (enExample)
IL (1) IL271326A (enExample)
TW (2) TWI842529B (enExample)
WO (1) WO2018231937A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115989872A (zh) * 2022-12-07 2023-04-21 山东欣希安药业股份有限公司 一种改善肿瘤患者营养状态的组合物及其制备方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102402485B1 (ko) 2016-10-03 2022-05-25 호운 사이먼 샤 암 방사선요법을 향상시키기 위한 조성물 및 방법
US12029765B2 (en) * 2017-06-13 2024-07-09 Houn Simon Hsia Compositions and methods for treating cancer
CA3066713A1 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
CN120695037A (zh) * 2017-06-13 2025-09-26 夏滉 用于加强过热疗法的组合物和方法
CN111479577A (zh) 2017-06-13 2020-07-31 夏滉 用于增强癌症放疗的组合物和方法
WO2020205885A1 (en) * 2019-04-01 2020-10-08 Houn Simon Hsia Compositions and methods for cancer immunotherapy
IL300523A (en) * 2020-08-10 2023-04-01 Houn Simon Hsia Materials and methods for treating viral infection
IT202100003899A1 (it) * 2021-02-19 2021-05-19 Genes S R L Integratore alimentare per il trattamento nutri-cosmetico dell'alopecia e la prevenzione cardiovascolare
CN115845056A (zh) * 2022-07-22 2023-03-28 山东大学齐鲁医院 DHA通过抑制心肌细胞中p38/ET-1通路在防治放射性心肌纤维化中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW425285B (en) * 1996-06-10 2001-03-11 Viva America Marketing Inc Fish oil and garlic nutritive supplement
US20140294795A1 (en) * 2013-03-28 2014-10-02 Houn Simon Hsia Nutritional Composition

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348483A (en) * 1981-01-23 1982-09-07 Universal Foods Corporation Method for the production of chromium yeast
US4569836A (en) 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
JPS59181159A (ja) 1983-03-30 1984-10-15 日東電工株式会社 布製外科用絆
CA2010511A1 (en) 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US20020010144A1 (en) 1994-04-29 2002-01-24 Robert Sobol Enhancing the sensitivity of tumor cells to therapies
US5976548A (en) 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US5810888A (en) 1997-06-26 1998-09-22 Massachusetts Institute Of Technology Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
WO2000007607A1 (en) 1998-08-04 2000-02-17 Kosbab, John, V. Nutrient and therapeutic compositions for the treatment of cancer
US7569551B2 (en) 2000-02-25 2009-08-04 The University Of British Columbia Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
US20050080468A1 (en) 2001-03-26 2005-04-14 Lawrence C. Christman Methods and apparatus for treating diseased tissue
WO2003035108A1 (en) 2001-10-25 2003-05-01 Ttc Co., Ltd. Immunopotentiators in thermotherapy for cancer
KR20040073559A (ko) 2002-01-11 2004-08-19 라쓰 마티아스 폴리페놀을 포함하는 영양성 제약 제제 및 암 치료에서의용도
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US8017147B2 (en) 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
US20090110674A1 (en) 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
WO2009157759A1 (en) * 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
CN102215836B (zh) 2008-09-19 2015-07-08 雀巢产品技术援助有限公司 预防或减轻在抗癌治疗期间的骨髓瘫痪或中性白细胞减少症的营养支持
US8257694B2 (en) 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
CA2763041C (en) 2009-05-29 2018-11-27 Robert A. Newman Compositions and methods for modulating lipid composition
KR101275724B1 (ko) 2009-12-09 2013-06-17 한국전자통신연구원 단일 기판 집적 회로 장치 및 그 제조 방법
US20110189220A1 (en) 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
JP5882889B2 (ja) 2010-03-15 2016-03-09 国立大学法人 岡山大学 抗腫瘍剤
JP2012001479A (ja) * 2010-06-16 2012-01-05 Ishikawa Prefecture 水溶性ビタミンｅ含有物より成る生体防御剤
US20120010688A1 (en) 2010-07-09 2012-01-12 Lamb Karl J Implantable conductive element and method of use inhyperthermic treatment
EP2598139A4 (en) 2010-07-26 2013-12-25 Chemotherapeutics Llc COMPOSITIONS AND METHODS FOR IMPROVING THE EFFICACY OF SYSTEMIC, HIPEC AND IP TREATMENTS AGAINST CANCER
WO2012122295A2 (en) 2011-03-07 2012-09-13 Ned Biosystems, Inc. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
WO2014054884A1 (ko) 2012-10-05 2014-04-10 연세대학교 산학협력단 민감화 물질을 포함하는 온열 치료용 조성물
US9072768B2 (en) 2013-01-22 2015-07-07 Kibow Biotech, Inc. Composition and method for increasing effectiveness of radiation or chemotherapy
US9107947B2 (en) 2013-01-31 2015-08-18 The Penn State Research Foundation Anti-cancer compositions and methods
WO2014159851A2 (en) 2013-03-13 2014-10-02 The Board Of Regents Of The University Of Texas System Novel low density lipoprotein nanocarriers for targeted delevery of omega-3 polyunsaturated fatty acids to cancer
DE202013002760U1 (de) * 2013-03-21 2014-06-23 Cc Pharma Gmbh Nahrungsergänzungsmittel zur medikationsorientierten Supplementierung
SI2991507T1 (sl) 2013-04-22 2020-02-28 Smartfish As Uporaba sestavka, ki vsebuje ribje olje in sok za zdravljenje raka in po zdravljenju raka
CN105705037A (zh) 2013-07-31 2016-06-22 株式会社明治 用于抑制肿瘤生长的营养组合物
CN105658226B (zh) 2013-08-16 2019-05-14 港大科桥有限公司 使用益生菌治疗癌症的方法和组合物
JP6340544B2 (ja) 2014-02-28 2018-06-13 パナソニックＩｐマネジメント株式会社 食器洗い機
US20170246136A1 (en) 2014-09-24 2017-08-31 OliVentures, Inc. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
CN105641000A (zh) 2015-06-01 2016-06-08 深圳市康道生物有限公司 一种含灰树花提取物的抗肿瘤组合物及其制备方法
CN105617358A (zh) * 2015-12-29 2016-06-01 广州市戴菊科技发展有限公司 一种具有抗肿瘤功能的医用食品及其制备方法
CN105768108A (zh) * 2016-03-10 2016-07-20 福格森（武汉）生物科技股份有限公司 一种适用于肿瘤患者服用的特膳食品
JP6376186B2 (ja) 2016-08-04 2018-08-22 トヨタ自動車株式会社 サスペンションメンバ
KR102402485B1 (ko) * 2016-10-03 2022-05-25 호운 사이먼 샤 암 방사선요법을 향상시키기 위한 조성물 및 방법
CA3066713A1 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
CN111479577A (zh) 2017-06-13 2020-07-31 夏滉 用于增强癌症放疗的组合物和方法
JP2020121479A (ja) 2019-01-30 2020-08-13 オリンパス株式会社 射出成形金型

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW425285B (en) * 1996-06-10 2001-03-11 Viva America Marketing Inc Fish oil and garlic nutritive supplement
US20140294795A1 (en) * 2013-03-28 2014-10-02 Houn Simon Hsia Nutritional Composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FAHMY , HANAN A.等: "Protective Effects of ω-3 fatty acids and/or Nano-selenium on cisplatin and ionizing radiation induced liver toxicity in rats" *
HANG WANG等: "Reduction of Splenic Immunosuppressive Cells and Enhancement of Anti-Tumor Immunity by Synergy of Fish Oil and Selenium Yeast" *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115989872A (zh) * 2022-12-07 2023-04-21 山东欣希安药业股份有限公司 一种改善肿瘤患者营养状态的组合物及其制备方法

Also Published As

Publication number Publication date
JP7336993B2 (ja) 2023-09-01
JP2025120284A (ja) 2025-08-15
KR102775757B1 (ko) 2025-02-28
CA3066749A1 (en) 2018-12-20
EP3638269A4 (en) 2021-03-17
KR20200078467A (ko) 2020-07-01
WO2018231937A2 (en) 2018-12-20
TW202342076A (zh) 2023-11-01
WO2018231937A3 (en) 2019-03-28
TWI805589B (zh) 2023-06-21
EP3638269A2 (en) 2020-04-22
TWI842529B (zh) 2024-05-11
JP2023105153A (ja) 2023-07-28
IL271326A (en) 2020-01-30
US11541079B2 (en) 2023-01-03
CN120695036A (zh) 2025-09-26
KR20250034519A (ko) 2025-03-11
JP2020523374A (ja) 2020-08-06
TW201902533A (zh) 2019-01-16
US10905723B2 (en) 2021-02-02
EP3638269B1 (en) 2025-12-17
US20210213071A1 (en) 2021-07-15
US20190054126A1 (en) 2019-02-21

Similar Documents

Publication Publication Date Title
CN111479577A (zh) 用于增强癌症放疗的组合物和方法
JP7465313B2 (ja) がん放射線療法を増強するための組成物および方法
KR102736425B1 (ko) 암 화학요법을 강화시키기 위한 조성물 및 방법
US20240350558A1 (en) Compositions and Methods for Treating Inflammation
HK40029109A (en) Compositions and methods for enhancing cancer radiotherapy
HK40011860A (en) Compositions and methods for enhancing cancer radiotherapy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40029109

Country of ref document: HK